"Companies Refuse to Lower Meningitis Vaccine Prices"

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

 

------------------------------------------------------------

 

September 27, 2002

 

INTERNATIONAL IMMUNIZATION NEWS

 

"Companies Refuse to Lower Meningitis Vaccine Prices"

PANA Wire Service (allafrica.com) (09/26/02)

 

Sources at a World Health Organization (WHO) meningitis meeting in Burkina Faso say that pharmaceutical companies have rejected requests to lower the price of the tetravalent meningitis vaccine to $1 a dose for countries that frequently experience epidemics of the disease.  The best offer was reportedly made by GlaxoSmithKline, at $2.75 a dose.  Experts said that many nations where the disease is prevalent, especially those in Africa, cannot afford the vaccine.  They also expressed concern that the vaccines currently being used in the African meningitis belt do not protect against the W135 strain, which they said could spread from Burkina Faso to other countries in the region.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.